SCHEMBL7728185

SCHEMBL7728185

CC(C)(C)OC(=O)N1C[C@H](N(C(=O)CN)C(=O)OC(C)(C)C)C[C@H]1C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
NR1H2 P55055 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
HTRA1 Q92743 1/20 0.33
HSD11B1 P28845 2/20 0.32
CYP1A2 P05177 1/20 0.32
POLB P06746 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
AGTR2 P50052 1/20 0.31
PTPN1 P18031 1/20 0.31
JAK2 O60674 1/20 0.31
JAK1 P23458 1/20 0.31
UCHL1 P09936 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7726101 1.00 HSD17B10 (0.34) HSD17B10NFKB1NFKB2RELANR1H2
SCHEMBL7727961 1.00 HSD17B10 (0.34) HSD17B10NFKB1NFKB2RELANR1H2
SCHEMBL7733526 0.89 PTPN1 (0.39) NFKB1NFKB2RELANR1H2SMN1; SMN2
SCHEMBL7733813 0.89 PTPN1 (0.39) NFKB1NFKB2RELANR1H2SMN1; SMN2
SCHEMBL7726393 0.89 PTPN1 (0.39) NFKB1NFKB2RELANR1H2SMN1; SMN2
SCHEMBL7722230 0.88 HSD17B10 (0.40) HSD17B10NFKB1NFKB2RELASMN1; SMN2
SCHEMBL7722056 0.88 HSD17B10 (0.40) HSD17B10NFKB1NFKB2RELASMN1; SMN2
SCHEMBL7727566 0.85 HTRA1 (0.34) HSD17B10NR1H2SMN1; SMN2HTRA1HSD11B1
SCHEMBL7727102 0.83 USP30 (0.40) NR1H2HTRA1UCHL1
SCHEMBL7726796 0.83 USP30 (0.40) NR1H2HTRA1UCHL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed
WO-2000001714-A1 EFFLUX PUMP INHIBITORS MICROCIDE PHARMACEUTICALS, INC. (US) 2000-01-13 WO disclosed